Difference between revisions of "Part:BBa K3897005"
Line 3: | Line 3: | ||
<partinfo>BBa_K3897005 short</partinfo> | <partinfo>BBa_K3897005 short</partinfo> | ||
− | pH-sensitive HR2 | + | pH-sensitive HR2 Aptamer, allows high affinity for HER2 receptor under low pH |
=Design= | =Design= |
Latest revision as of 02:52, 9 October 2021
pH-sensitive HR2 Aptamer, allows high affinity for HER2 receptor under low pH
pH-sensitive HR2 Aptamer, allows high affinity for HER2 receptor under low pH
Design
Based on the design in previous literature[1], we adopted a similar design by switching out ATP aptamer with HR2 aptamer[2]. pHs-HR2 consists of 3 parts: - HR2 aptamer - pH-sensitive DNA switch - Complementary strand for HR2 aptamer The 5' end of the DNA switch connects the HR2 aptamer and the 3' end connects the complementary strand. When at normal pH (7.1), the DNA switch will form a duplex shape, which places the two ends together. Thus, HR2 aptamer is inhibited by complementary strand. When the aptamer is placed in low pH (6.5), protonation of the bases occurs and stabilizes C·G Hoogsteen base pairing, which folds the ssDNA chain into a triplex. The triplex shape separates the two ends so the aptamer functions normally.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Reference
-
li>Thompson, I., Zheng, L., Eisenstein, M., & Soh, H. T. (2020). Rational design of aptamer switches with programmable pH response. Nature communications, 11(1), 2946. https://doi.org/10.1038/s41467-020-16808-
- Liu, Z., Duan, J. H., Song, Y. M., Ma, J., Wang, F. D., Lu, X., & Yang, X. D. (2012). Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. Journal of translational medicine, 10, 148.https://doi.org/10.1186/1479-5876-10-148